2011
DOI: 10.18388/abp.2011_2293
|View full text |Cite
|
Sign up to set email alerts
|

Antitumor activity of antimicrobial peptides against U937 histiocytic cell line.

Abstract: We investigated cytotoxic activity of antimicrobial peptides of different origin (both naturally occurring and synthetic), structure and known mechanisms of action against human histiocytic lymphoma cell line U937. The strongest cytotoxic activity against U937 cell line was shown by Pexiganan MSI-78, followed by Citropin 1.1, Protegrin 1 and a synthetic lipopeptide, N-α-palmitoyl-L-lysyl-L-lysine amide (Pal-Lys-Lys-NH₂). The cytotoxic activity of the peptides was more dependent on the time of incubation than c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
21
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(23 citation statements)
references
References 62 publications
2
21
0
Order By: Relevance
“…It has been shown that the cytotoxic activity of buforin II is low when compared with citropin 1.1, pexiganan MSI-78 and protegrin 1, and that it does not permanently disrupt the cell membrane like other molecules, i.e., its antitumor activity corroborates with the mechanism described above (Koszalka et al, 2011). A synthetic analog of buforin II named buforin IIb has shown greater cytolytic activity against cancer cells (leukemia, breast cancer, non-small cell lung cancer, CNS cancer, melanoma, renal, ovarian, prostate, and colon cancer) than buforin II (Lee et al, 2008).…”
Section: Introductionsupporting
confidence: 66%
“…It has been shown that the cytotoxic activity of buforin II is low when compared with citropin 1.1, pexiganan MSI-78 and protegrin 1, and that it does not permanently disrupt the cell membrane like other molecules, i.e., its antitumor activity corroborates with the mechanism described above (Koszalka et al, 2011). A synthetic analog of buforin II named buforin IIb has shown greater cytolytic activity against cancer cells (leukemia, breast cancer, non-small cell lung cancer, CNS cancer, melanoma, renal, ovarian, prostate, and colon cancer) than buforin II (Lee et al, 2008).…”
Section: Introductionsupporting
confidence: 66%
“…Certain AMPs such as pexiganan MSI-78, citropin 1.1, protegrin 1, synthetic lipopeptide, and N- α -palmitoyl-L-lysine–L-lysine amide (Pal-Lys-Lys-NH 2 ) showed cytotoxic activity against U937 histiocytic cell line. Of these, pexiganan MSI-78, protegrin 1, and lipopeptide showed increased tumoricidal activity due to their stronger membranolytic activity that leads to necrosis [120]. Cecropins A and B showed selective inhibitory and antiproliferative efficacy against bladder tumour cells lines, RT4, 647V, J82, 486P, and benign fibroblast cell line, 3T6 [101].…”
Section: Multidimensional Properties Of Ampsmentioning
confidence: 99%
“…Out of a range of antimicrobial peptides tested, the magainin-2 analog, pexiganan shows the greatest cytotoxic activity against the U937 human histiocytic lymphoma cell line [70]. The anti-tumor activity of protease-resistant all D-amino acid magainin-2 amide (MSI-238) is markedly superior to the parent compound displaying high potency in vitro against non-small cell lung adenocarcinoma A549 cells and in vivo against P388 leukemia, S180 ascites, and a spontaneous ovarian tumor [71].…”
Section: Peptides With Anti-cancer Activitymentioning
confidence: 99%